Consequently, inhibition of AChE, BChE, β-amyloid cleaving enzyme (BACE1/beta secretase), MAO and free radicals have shown promise in the development of therapeutic agents against AD (Reisberg et al., 2003; Birks, 2006). Here, BCHE is linked to Alzheimer disease.